1.66
price up icon5.06%   0.08
after-market Dopo l'orario di chiusura: 1.66
loading

180 Life Sciences Corp Azioni (ATNF) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
44.06%
2.0925
1.4525 3.5382 3.683 4.8038
Interest Income/Expense
63.97%
0.0164
0.01 0.0116 0.0116 0.0565
Operating Income/Loss
44.06%
-2.0925
-1.4525 -3.5382 -3.683 -4.8038
Nonoperating Income/Loss
362.78%
1.0227
0.221 -9.0726 0.00281 0.0418
Income/Loss From Continuing Operations Before Tax
13.13%
-1.0697
-1.2315 -12.61 -3.6802 -4.7621
Income/Loss From Continuing Operations After Tax
12.82%
-1.0697
-1.2271 -10.27 -3.6802 -4.7621
Net Income/Loss
12.82%
-1.0697
-1.2271 -10.27 -3.6802 -4.7621
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
112.09%
0.6383
-5.2797 7.952 5.2313 3.7471
Diluted Average Shares
0.6383
- 7.952 5.2313 3.7471
Basic Earnings Per Share
96.59%
-1.68
-49.28 -1.29 -0.70 -1.27
Diluted Earnings Per Share
96.59%
-1.68
-49.28 -1.29 -0.70 -1.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$22.18
price up icon 1.46%
$73.19
price up icon 1.78%
$362.33
price up icon 1.95%
$47.53
price up icon 11.65%
biotechnology ONC
$175.10
price down icon 3.07%
$126.88
price up icon 5.55%
Capitalizzazione:     |  Volume (24 ore):